Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

BETA is published quarterly by the San Francisco AIDS Foundation.

BETA
Main page

Subscribe (free)

Contact Us
beta@sfaf.org

October 1998 Table of Contents

Features

A New Approach to Initial Antiretroviral Therapy: Protease-Sparing Combination Regimens

Post-Exposure Prophylaxis: Still More Questions than Answers
Tuberculosis

Departments

BETA News Briefs

Drug Watch
-- Hydroxyurea
-- FddA: Antiretroviral in Development
-- ABT-378: A Second Generation Protease Inhibitor

Women and HIV
-- Highlights on Women and Pregnancy from the 12th World AIDS Conference

Conference Coverage
-- Vaccine News from the 12th World AIDS Conference
-- Selected Highlights from the 12th World AIDS Conference
Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Contributors to this issue:

  • Harvey S. Bartnof, MD
  • Christopher Gortner
  • Leslie Hanna
  • Liz Highleyman
  • Bruce Mirken
  • Katy Stephenson

Page last updated 6 October 1998


About AIDS | Treatment | Prevention | Policy | About SFAF | Take Action | Donate
 Espaņol | Search | Site Map | Feedback | Email Updates | Home (sfaf.org)